Antibody seroprevalence and economic implications of COVID-19 | Jay Bhattacharya

Conversation Menu


In the first IDFC Institute webinar, Dr Jay Bhattacharya, Professor of Medicine at Stanford University, spoke to Dr Reuben Abraham about his recent findings on antibody seroprevalence and economic implications of COVID-19.


Dr Jay Bhattacharya

Dr. Bhattacharya is a Professor of Medicine at Stanford University, is a research associate at the National Bureau of Economics Research, a senior fellow at the Stanford Institute for Economic Policy Research, and at the Stanford Freeman Spogli Institute. He holds courtesy appointments as Professor in Economics and in Health Research and Policy. He directs the Stanford Center on the Demography of Health and Aging. Dr. Bhattacharya’s research focuses on the economics of health care around the world with a particular emphasis on the health and well-being of vulnerable populations. Dr. Bhattacharya’s peer-reviewed research has been published in economics, statistics, legal, medical, public health, and health policy journals. He holds an MD and PhD in economics from Stanford University.

x Close Window


Please note that we have limited seats, and may not be able to confirm your RSVP. Submitting this form does not provide access to this event. If we are able to accommodate your RSVP, you will receive a separate confirmation email from us. Thank you for your interest.

x Close Window

Please verify your email address to access this content